ijms-logo

Journal Browser

Journal Browser

Microbiota and Sepsis: Interactions and Future Perspectives

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".

Deadline for manuscript submissions: closed (15 October 2023) | Viewed by 1974

Special Issue Editor


E-Mail Website
Guest Editor

Special Issue Information

Dear Colleagues,

Dysbiosis in septic patients may play a role in determining the course of the disease by increasing systemic pro-inflammatory cytokine production. The microbiota could have therapeutic properties, although the underlying mechanism for the observed dysbiosis is unclear. Mounting evidence suggests that severe infection may have an impact on the host microbiota and gut inflammation, infecting intestinal epithelial cells and involving the microvascular system of the gastrointestinal tract. This possible link and its implications can be investigated by observing the effects of the modulation of the microbial flora in critically ill patients with severe infections.

Moreover, new data from the pandemic have highlighted the role of the lung microbiota and the dysregulation of the gut–brain–lung axis. Therefore, knowledge of the molecular mechanisms associated with microbiota modifications in septic patients and new therapeutic approaches is necessary for the early and appropriate management of severe infections. Data about the types of interventions that are the most effective according to the personal characteristics of individual patients are required.

This Special Issue aims to expand the current knowledge of the interactions between microbiota and sepsis in different stages and possible therapeutic exploitations, including new therapies. Experimental studies using in vitro and in vivo models, review articles, and clinical studies are all welcome to be submitted.

Dr. Alessandro Russo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • sepsis
  • septic shock
  • microbiome
  • microbionutritional status
  • MDR pathogens
  • therapeutic approaches

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

14 pages, 1784 KiB  
Review
The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives
by Nadia Marascio, Giuseppe Guido Maria Scarlata, Francesco Romeo, Claudia Cicino, Enrico Maria Trecarichi, Angela Quirino, Carlo Torti, Giovanni Matera and Alessandro Russo
Int. J. Mol. Sci. 2023, 24(11), 9307; https://doi.org/10.3390/ijms24119307 - 26 May 2023
Cited by 3 | Viewed by 1633
Abstract
Sepsis is a life-threatening multiple-organ dysfunction caused by a dysregulated host response to infection, with high mortality worldwide; 11 million deaths per year are attributable to sepsis in high-income countries. Several research groups have reported that septic patients display a dysbiotic gut microbiota, [...] Read more.
Sepsis is a life-threatening multiple-organ dysfunction caused by a dysregulated host response to infection, with high mortality worldwide; 11 million deaths per year are attributable to sepsis in high-income countries. Several research groups have reported that septic patients display a dysbiotic gut microbiota, often related to high mortality. Based on current knowledge, in this narrative review, we revised original articles, clinical trials, and pilot studies to evaluate the beneficial effect of gut microbiota manipulation in clinical practice, starting from an early diagnosis of sepsis and an in-depth analysis of gut microbiota. Full article
(This article belongs to the Special Issue Microbiota and Sepsis: Interactions and Future Perspectives)
Show Figures

Figure 1

Back to TopTop